{
  "ticker": "RGT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967107",
  "id": "02967107",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250708",
  "time": "0926",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250708/pdf/06ll350bd54grs.pdf",
  "summary": "**Material Information Summary:**  \n\n- **Commercial Milestone:** Commenced formal supply of EU-GMP cannabinoid API to University Medical Centre Ljubljana (Slovenia) for epilepsy treatment, transitioning from pilot to routine hospital use.  \n- **Strategic Impact:** Validates regulatory/clinical pathway for EU expansion; strengthens Epilepsy Program Platform (EPP) with potential for further hospital partnerships.  \n- **Regulatory Leadership:** Collaboration with Slovenian health authorities (MoH, JAZMP) established framework for hospital compounding of cannabinoid therapies.  \n\n*No capital raising, financial data, or trading-sensitive details identified.*",
  "usage": {
    "prompt_tokens": 1514,
    "completion_tokens": 126,
    "total_tokens": 1640,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-07T23:34:12.398092"
}